The role of the central nervous system in the psychoneuroendocrine disturbances of anorexia and bulimia nervosa

Psychiatric Clinics of North America

Volumn 21, Issue 2, 1998, Pages 381-396

  Kaye, W H ^a   Gendall, K ^a   Kye, C ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; FOLLITROPIN; GROWTH HORMONE; HYDROCORTISONE; LEPTIN; LIOTHYRONINE; LUTEINIZING HORMONE; NEUROPEPTIDE; NEUROPEPTIDE Y; OPIATE PEPTIDE; OXYTOCIN; PEPTIDE YY; PROLACTIN; THYROTROPIN; THYROXINE; VASOPRESSIN;

ANOREXIA; BULIMIA; CENTRAL NERVOUS SYSTEM; DYSPHORIA; HUMAN; NEUROENDOCRINOLOGY; NONHUMAN; OBSESSION; PRIORITY JOURNAL; REVIEW; STARVATION; WEIGHT REDUCTION;

EID: 0031808262     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(05)70011-3     Document Type: Article

References (105)

1. S.A. Agger M.D. Schwalberg J.M. Bigaouette Effect of a tricyclic antidepressant and opiate antagonist on binge eating behavior in normal weight bulimia and obese, binge-eating subjects Am J Clin Nutr 53 1991 865 871
2. R.S. Ahima D. Prabakaran C. Mantzoros Role of leptin in the neuroendocrine response to fasting Nature 382 1996 250 252
3. Y.S. Allen T.E. Adrian J.M. Allen Neuropeptide Y distribution in the rat brain Science 221 1983 877 879
4. American Psychiatric Association: Diagnostic and statistical manual of mental disorders. (DSM-IV). Washington, DC, 1994
5. M. Armeanu G.M.J. Berkhout J. Schoemaker Pulsatile luteinizing hormone secretion in hypothalamic amenorrhea, anorexia nervosa, and polycystic ovarian disease during naltrexone treatment Fertil Steril 57 1992 762 770
6. J.M. Baraban B.T. Walsh M. Gladis Effect of naloxone on luteinizing hormone secretion in eating disorders: A pilot study Int J Eat Disor 5 1986 149 155
7. B. Baranowska G. Rozbicka W. Jeske The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: The effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphine secretion J Clin Endocrinol Metab 59 1984 412 416
8. M. Berger K. Pirke P. Doerr Influence of weight loss on the dexamethasone suppression test Arch Gen Psychiatry 40 1983 585 586
9. G. Bissette C.B. Nemeroff The role of neuropeptides in the pathogenesis and treatment of schizophrenia C.B. Nemeroff Neuropeptides in Psychiatric and Neurological Disorders 1988 John Hopkins University Press Baltimore 49 75
10. G. Boden X. Chen M. Mazzoli Effect of fasting on serum leptin in normal subjects J Clin Endocrinol Metab 81 1996 3419 3423
11. B. Bohus G.L. Kovacs D. De Weid Oxytocin, vasopressin and memory: Opposite effects on consolidation and retrial processes Brain Res 157 1978 414 417
12. D.L. Braun S.R. Sunday K.A. Halmi Psychiatric comorbidity in patients with eating disorders Psychol Med 24 1994 859 867
13. T.D. Brewerton R.B. Lydiard D.B. Herzog Comorbidity of axis I psychiatric diagnosis in bulimia nervosa J Clin Psychiatry 56 1995 77 80
14. T.D. Brewerton R.B. Lydiard M.T. Laraia CSF beta-endorphin and dynorphin in bulimia nervosa Am J Psychiatry 149 1992 1086 1090
15. D.R. Britton G.R. Koob J. Rivier Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty Life Sci 31 1982 363 367
16. R.C. Casper R.T. Chatterton J.M. Davis Alterations in serum cortisol and its binding characteristics in anorexia nervosa J Clin Endocrinol Metab 49 1979 406 411
17. F.F. Chehab M.E. Lim R. Lu Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin Nat Genet 112 1996 318 320
18. F.F. Chehab K. Mounzih R. Lu Early onset of reproductive function in normal female mice treated with leptin Science 265 1997 88 90
19. H. Chen O. Charlat L.A. Tartaglia Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice Cell 84 1996 491 495
20. P. Chiodera R. Volpi L. Capretti Effect of estrogen or insulin-induced hypoglycemia on plasma oxytocin levels in bulimia and anorexia nervosa Metabolism 40 1991 1226 1230
21. J.C. Clapham S.A. Smith G.B.T. Moore Plasma leptin concentrations and OB gene expression in subcutaneous adipose tissue are not regulated by acutely physical hyperinsulinaemia in lean and obese humans Int J Obes Relat Metab Disord 21 1997 179 183
22. J.T. Clark P.S. Kaira S.P. Kalra Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats Endocrinology 117 1985 2435 2442
23. S. Collins C.M. Kuhn A.E. Petro Role of leptin in fat regulation Nature 380 1996 677
24. R.V. Considine M. Sinha M.L. Heiman Serum immunoreactive-leptin concentrations in normal-weight and obese humans N Engl J Med 334 1996 292 295
25. M.A. Demitrack K.T. Kalogeras M. Altemus Plasma and cerebrospinal fluid measures of arginine vasopressin secretion in patients with bulimia nervosa and in healthy subjects J Clin Endocrinol Metab 74 1992 1277 1283
26. M.A. Demitrack M.D. Lesem S.J. Listwak CSF oxytocin in anorexia nervosa and bulimia nervosa: Clinical and pathophysiologic considerations Am J Psychiatry 147 1990 882 886
27. D. De Weid The influences of the posterior and intermediate lobe of the pituitary and pituitary peptides on the maintenance of a conditioned avoidance response in rats Neuropharmacology 4 1965 157 167
28. T.P. Donohoe Stress-induced anorexia: Implications for anorexia nervosa Life Sci 34 1984 203 218
29. C.K. Edelstein P. Roy-Byrne F.L. Fawy Effects of weight loss on the dexamathasone suppression test Am J Psychiatry 140 1983 338 341
30. J.C. Erikson K.E. Clegg R.D. Palmiter Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y Nature 381 1996 415 421
31. F. Ferron R.V. Considine R. Peino Serum leptin concentrations in patients with anorexia nervosa, bulimia nervosa and non-specific eating disorders correlate with body mass index but are independent of the respective disease Clin Endocrinol 46 1997 289 293
32. M.M. Fichter K.M. Pirke Psychobiology of human starvation. Child and Youth Psychiatry: European Perspectives Anorexia Nervosa 1 1990 13 29
33. M.M. Fichter K.M. Pirke Starvation models and eating disorders G. Szmukler C. Dare J. Treasure Handbook of Eating Disorders: Theory, Treatment and Research 1995 John Wiley &Sons West Sussex, UK
34. M.M. Fichter K.M. Pirke F. Holsboer Weight loss causes neuroendocrine disturbances: Experimental studies in healthy starving subjects Psychiatry Res 17 1986 61 72
35. M.M. Fichter K.M. Pirke J. Pollinger Restricted caloric intake causes neuroendocrine disturbances in bulimia The Psychobiology of Bulimia 1988 42 56
36. M.L. Forsling Regulation of oxytocin release D. Pfaff D. Ganen Current Topics in Neuroendocrinology vol 6 1986 Springer-Verlag New York 19 53
37. K. Fuxe L.F. Agnati A. Harfstrand Central administration of neuropeptide Y induces hypotension, bradypnea and EEG synchronization in the rat Acta Physiol Scand 118 1983 189 192
38. E. Garcia-Rubi D. Vazquez-Aleman J.P. Mendez The effects of opioid blockade and GnRH administration upon luteinizing hormone secretion in patients with anorexia nervosa during the stages of weight loss and weight recovery Clin Endocrinol 37 1992 520 528
39. P.E. Garfinkel E. Lin P. Goering Bulimia nervosa in a Canadian community sample: prevalence and comparison of subgroups Am J Psychiatry 152 1995 1052 1058
40. M. Giusti R. Torre L. Traverso Endogenous opioid blockade and gonadotropin secretion: Role of pulsatile luteinizing hormone-releasing hormone administration in anorexia nervosa and weight loss amenorrhea Fertil Steril 49 1988 797 801
41. P.W. Gold G. Chrousos C. Kellner Psychiatric implications of basic and clinical studies with corticotropin-releasing factor Am J Psychiatry 141 1984 619 627
42. P.W. Gold H. Gwirtsman P.C. Avgerinos Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa: Pathophysiologic mechanisms in underweight and weight-corrected patients N Engl J Med 314 1986 1335
43. P.W. Gold W.H. Kaye G.L. Robertson Abnormalities in plasma and cerebrospinal-fluid arginine vasopressin in patients with anorexia nervosa N Engl J Med 308 1983 1117 1123
44. S. Grinspoon T. Gulick H. Askari Serum leptin levels in women with anorexia nervosa J Clin Endocrinol Metab 81 1996 3861 3864
45. A. Grossman Brain opiates and neuroendocrine function J Clin Endocrinol Metab 12 1983 725
46. D.A. Haas S.R. George Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: Lack of effect in other rat brain regions Life Sci 41 1987 2725 2731
47. A. Hamann S. Matthaei Regulation of energy balance by leptin Exp Clin Endocrinol Diabetes 104 1996 293 300
48. R.B.S. Harris T.G. Ramsay S.R. Smith Early and late stimulation of ob mRNA expression in meal-fed and overfed rats J Clin Invest 97 1996 2020 2026
49. J. Hebebrand J. Van der heyden R. Devos Plasma concentrations of obese protein in anorexia nervosa Lancet 346 1995 1624 1625
50. D.B. Herzog M.B. Keller N.R. Sacks Psychiatric comorbidity in treatment-seeking anorexics and bulimics J Am Acad Child Adolesc Psychiatry 31 1992 810 818
51. C.C. Holderness J. Brooks-Gunn W.P. Warren Co-morbidity of eating disorders and substance abuse: Review of the literature Int J Eat Disord 16 1994 1 34
52. M. Hotta T. Shibasaki A. Masuda The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients J Clin Endocrinol Metab 62 1986 319 324
53. J.I. Hudson H.G. Pope The Psychobiology of Bulimia 1987 American Psychiatry Press Washington, DC
54. B. Ishizuka M.E. Quigley S.S. Yen Pituitary hormone release in response to food ingestion: Evidence for neuroendocrine signals from gut to brain J Clin Endocrinol Metab 57 1983 1111
55. J.M. Jonas M.S. Gold Naltrexone reverse bulimic symptoms Lancet 1 1986 807
56. J.M. Jonas M.S. Gold Treatment of antidepressant resistant bulimia with naltrexone Int J Psychiatry Med 16 1987 305 309
57. J.M. Jonas M.S. Gold The use of opiate antagonists in treating bulimia: a study of low dose versus high dose naltrexone Psychiatry Res 24 1988 195 199
58. S.P. Kalra L.G. Allen J.T. Clark Neuropeptide Y—an integrator of reproductive and appetitive functions T.W. Moody Neural and Endocrine Peptides and Receptors 1986 Plenum Press New York 353 366
59. W.H. Kaye W. Berrettini H. Gwirtsman Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa Arch Gen Psychiatry 147 1990 548 556
60. W.H. Kaye W.H. Berretini H.E. Gwirtsman Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelancortin related peptides (including β-endorphin) in anorexia nervosa Life Sci 41 1987 2147 2155
61. W.H. Kaye H.E. Gwirtsman D.T. George Elevated cerebrospinal fluid levels of immunoreactive corticotropin releasing hormone in anorexia nervosa: Relation to state of nutrition, adrenal function and intensity of depression J Clin Endocrinol Metab 64 1987 203 208
62. Kaye WH, Nagata T, Hsu LKG, et al: Successful outcome of restricting type anorexia nervosa after the double-blind placebo-controlled administration of fluoxetine. Am J Psychiatry, in press
63. W.H. Kaye D. Pickar D. Naber Cerebrospinal fluid opioid activity in anorexia nervosa Am J Psychiatry 139 1982 643 165
64. A. Keys J. Brozek A. Henschel The Biology of Human Starvation 1950 University of Minnesota Press Minneapolis, MN 767 853
65. W. Kopp W.F. Blom S. Von Prittwitz Low leptin levels predict amenorrhea in underweight and eating disordered females Molecular Psychiatry 2 1997 335 340
66. R.G. Laessle H.U. Wittchen M.M. Fichter The significance of subgroups of bulimia and anorexia nervosa: Lifetime frequency of psychiatric disorders Int J Eat Disord 8 1989 569 574
67. J.J. Legros P. Chiodera E. Demy-Ponsart Inhibitory influence of exogenous oxytocin on adrenocorticotropin secretion in normal human subjects J Clin Endocrinol Metab 55 1982 1035 1039
68. S.F. Leibowitz L. Hor Endophinergic and alpha-noradrenergic systems in the paraventricular nucleus: Effects on eating behavior Peptides 3 1982 421 428
69. M.D. Lesem W.H. Berrettini W.H. Kaye Measurement of CSF dynorphin A 1-8 immunoreactivity in anorexia nervosa and normal-weight bulimia Biol Psychiatry 29 1991 244 252
70. J. Licinio M.L. Wong P.W. Gold The hypothalamic-pituitary-adrenal axis in anorexia nervosa Psychiatry Res 62 1996 75 83
71. C. Mantzoros J.S. Flier M.D. Lesem Cerebrospinal fluid leptin in anorexia nervosa: Correlation with nutritional status and potential role in resistance to weight gain J Clin Endocrinol Metab 82 1997 1845 1851
72. M.A. Marrazzi J.P. Bacon J. Kinzie Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa Int Clin Psychopharmacol 10 1995 163 172
73. M.A. Marrazzi E.D. Luby An auto-addiction opioid model of chronic anorexia nervosa Int J Eat Disord 5 1986 191 208
74. J.B. Martin S. Reichlin The neurohypophysis: Physiology and disorders of secretion F.A. Davis Clinical Neuroendocrinology ed 2 1987 Davis Philadelphia 67 109
75. J.E. Mitchell G. Christenson J. Jennings A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia J Clin Psychopharmacol 9 1989 94 97
76. J.E. Mitchell N. Raymond S. Specker A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa Int J Eating Disorders 14 1993 229 147
77. R. Moore I.H. Mills A. Forster Naloxone in the treatment of anorexia nervosa: Effect on weight J R Soc Med 74 1981 129 131
78. J.E. Morley J.E. Blundell The neurobiological basis of eating disorders: Some formulations Biol Psychiatry 23 1988 53 78
79. J.E. Morley A.S. Levine M. Grace Peptide YY (PYY), a potentorexigenic agent Brain Res 341 1985 200 203
80. J.E. Morley A.S. Levine G.K. Yim Opioid modulation of appetite Neurosci Biobehav Rev 7 1983 281 305
81. C.B. Nemeroff E. Widerkiv G. Bissett Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients Science 226 1984 1342 1344
82. F. Nybert A. Wahlstrom B. Sjolund Characterization of electrophoretically separable endorphins in human CSF Brain Res 259 1983 267
83. M.Z. Pelleymounter M. Cullen M.J. Baker Effects of the obese gene product on body weight regulation in ob/ob mice Science 269 1995 540 543
84. A. Pfeiffer A. Herz Endocrine actions of opioids Horm Metab Res 16 1984 386 397
85. K.M. Pirke J. Pahl U. Schweiger Metabolic and endocrine indices of starvation in bulimia: A comparison with anorexia nervosa Psychiatry Res 15 1985 33 39
86. D.W. Ploog K.M. Pirke Psychobiology of anorexia nervosa Psychol Med 17 1987 843 859
87. C. Pollice W.H. Kaye C.G. Greeno Relationship of depression, anxiety, and obsessionality to state of illness in anorexia nervosa Int J Eat Disord 21 1997 367 376
88. L. Recant N. Voyles A. Wade Studies on the role of opiate peptides in two forms of genetic obesity: Ob/ob mouse fa/fa rat Horm Metab Res 15 1983 589
89. L.D. Reid Endogenous opioid peptides and the regulation of drinking and feeding Am J Clin Nutr 42 1985 1099 1132
90. C. Rivier W. Vale Influence of corticotropin-releasing factor on reproductive functions in the rat Endocrinology 114 1984 914 921
91. A. Sahu P.S. Kalra S.P. Kalra Food deprivation and ingestion induces reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus Peptides 9 1988 83 86
92. M.K. Sinha J.P. Ohannesian M.L. Helman Nocturnal rise of leptin in lean, obese and non-insulin dependent diabetes mellitus subjects J Clin Invest 97 1996 1344 1347
93. D.J. Sirinathsinghji L.H. Rees J. Rivier Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat Nature 305 1983 232 235
94. S.R. Smith T. Bledsoe M.K. Chetri Cortisol metabolism and the pituitary-adrenal axis in adults with protein-calorie malnutrition J Clin Endocrinol Metab 40 1975 43
95. B.C. Stanley D.R. Daniel A.S. Chin Paraventricular nucleus injections of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion Peptides 6 1985 1205 1211
96. T.W. Stephens M. Basinski P.K. Bristow The role of neuropeptide Y in the antiobesity action of the obese gene product Nature 377 1995 530 533
97. M. Strober Depression in the eating disorders: A review and analysis of descriptive, family and biological findings D.M. Garner P.E. Garfinkel Diagnostic issues in Anorexia Nervosa and Bulimia Nervosa 1980 Brunner/Mazel New York 80 111
98. R.E. Sutton G.F. Koob M. LeMoal Corticotropin-releasing factor produces behavioral activation in rats Nature 297 1982 331 333
99. G.I. Szmukler D. Tantam Anorexia nervosa: Starvation dependence Br J Med Psychol 57 1984 303 310
100. L.A. Tartaglia M. Dembski X. Weng Identification and expression cloning of a leptin receptor, OB-R Cell 83 1995 1263 1271
101. P. Trayhurn M.E.A. Thomas J.S. Duncan Effects of fasting and refeeding on ob gene expression in white adipose tissue of lean and obese (ob/ob) mice FEBS Letters 368 1995 488 490
102. L. Tseng D.S. Cheng Acute and chronic administration of beta-endorphin and naloxone on food and water intake in rats Fed Proc 39 1980 606 [abstract #1806]
103. B.T. Walsh Psychopharmacologic treatment of bulimia nervosa J Clin Psychiatry 52 suppl 10 1991 34 38
104. B.T. Walsh J.L. Katz J. Levin Adrenal activity in anorexia nervosa Psychosom Med 40 1978 499
105. Y. Zhang R. Proenca M. Maffei Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432